ADVERTISEMENT
Latest Blogs, Articles, and More
Keytruda Granted Breakthrough Status for Lung Cancer
The FDA has granted a breakthrough therapy designation to the immunotherapy drug Keytruda (pembrolizumab) for the treatment of patients with non-small cell lung cancer.
Integrated Care Model Emerges for Oncologic Emergencies
In September, The Ohio State University Comprehensive Cancer Center, collaborating with the Department of Emergency Medicine, opened a fully integrated cancer emergency department at the new James Cancer Hospital to care for patients who develop emergencies caused by their cancers.
Study Shows PARP Inhibitor Veliparib Could Help Patients with Squamous Cell Lung Cancer
Preliminary data from a phase 2 trial demonstrates that a combination of the PARP inhibitor veliparib and chemotherapy benefits patients with squamous cell non-small cell lung cancer.
Parenting with Advanced Cancer
Being a parent affects EVERY decision in my life, even the ones regarding my cancer care.
Patients Have a New Option When Facing Chemotherapy-Induced Nausea and Vomiting
Recently approved Akynzeo prevents common side effect with a combination approach
Special Feature


Nominate an extraordinary oncology nurse
Send us your essay nomination before February 20, 2015, for the chance to join CURE in honoring your oncology nurse! Submit your essay today!
[ Learn more ]
ADVERTISEMENT
ADVERTISEMENT
$auto_registration$